no code implementations • NeurIPS 2021 • Ruoxi Sun, Hanjun Dai, Li Li, Steven Kearnes, Bo Dai
In this paper, we propose a framework that unifies sequence- and graph-based methods as energy-based models (EBMs) with different energy functions.
no code implementations • NeurIPS Workshop AI4Scien 2021 • Kehang Han, Steven Kearnes, Jin Xu, Wen Torng, JW Feng
DNA-Encoded Libraries (DEL thereafter) data, often with millions of data points, enables large deep learning models to make real contributions in the drug discovery process (e. g., hit-finding).
no code implementations • 26 Aug 2020 • Steven Kearnes
Retrospective testing of predictive models does not consider the real-world context in which models are deployed.
no code implementations • 14 Jul 2020 • Ruoxi Sun, Hanjun Dai, Li Li, Steven Kearnes, Bo Dai
Retrosynthesis -- the process of identifying a set of reactants to synthesize a target molecule -- is of vital importance to material design and drug discovery.
Ranked #5 on Single-step retrosynthesis on USPTO-50k
no code implementations • 31 Jan 2020 • Kevin McCloskey, Eric A. Sigel, Steven Kearnes, Ling Xue, Xia Tian, Dennis Moccia, Diana Gikunju, Sana Bazzaz, Betty Chan, Matthew A. Clark, John W. Cuozzo, Marie-Aude Guié, John P. Guilinger, Christelle Huguet, Christopher D. Hupp, Anthony D. Keefe, Christopher J. Mulhern, Ying Zhang, Patrick Riley
We demonstrate a new approach applying machine learning to DEL selection data by identifying active molecules from a large commercial collection and a virtual library of easily synthesizable compounds.
no code implementations • 18 Apr 2019 • Steven Kearnes, Li Li, Patrick Riley
We present RL-VAE, a graph-to-graph variational autoencoder that uses reinforcement learning to decode molecular graphs from latent embeddings.
7 code implementations • 19 Oct 2018 • Zhenpeng Zhou, Steven Kearnes, Li Li, Richard N. Zare, Patrick Riley
We present a framework, which we call Molecule Deep $Q$-Networks (MolDQN), for molecule optimization by combining domain knowledge of chemistry and state-of-the-art reinforcement learning techniques (double $Q$-learning and randomized value functions).
Ranked #1 on Molecular Graph Generation on ZINC (QED Top-3 metric)
4 code implementations • 22 Feb 2018 • Nathaniel Thomas, Tess Smidt, Steven Kearnes, Lusann Yang, Li Li, Kai Kohlhoff, Patrick Riley
We introduce tensor field neural networks, which are locally equivariant to 3D rotations, translations, and permutations of points at every layer.
no code implementations • J. Chem. Theory Comput. 2017 • Felix A. Faber, Luke Hutchison, Bing Huang, Justin Gilmer, Samuel S. Schoenholz, George E. Dahl, Oriol Vinyals, Steven Kearnes, Patrick F. Riley, O. Anatole von Lilienfeld
We investigate the impact of choosing regressors and molecular representations for the construction of fast machine learning (ML) models of thirteen electronic ground-state properties of organic molecules.
Ranked #18 on Formation Energy on QM9
no code implementations • 28 Jun 2016 • Steven Kearnes, Brian Goldman, Vijay Pande
Deep learning methods such as multitask neural networks have recently been applied to ligand-based virtual screening and other drug discovery applications.
1 code implementation • 6 Jun 2016 • Steven Kearnes, Vijay Pande
Rapid overlay of chemical structures (ROCS) is a standard tool for the calculation of 3D shape and chemical ("color") similarity.
2 code implementations • 2 Mar 2016 • Steven Kearnes, Kevin McCloskey, Marc Berndl, Vijay Pande, Patrick Riley
Molecular "fingerprints" encoding structural information are the workhorse of cheminformatics and machine learning in drug discovery applications.
Ranked #11 on Drug Discovery on QM9
1 code implementation • 6 Feb 2015 • Bharath Ramsundar, Steven Kearnes, Patrick Riley, Dale Webster, David Konerding, Vijay Pande
Massively multitask neural architectures provide a learning framework for drug discovery that synthesizes information from many distinct biological sources.